NCT04276649View on ClinicalTrials.gov

A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis

CompletedOBSERVATIONAL
Enrollment

74

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

March 31, 2021

Conditions
Ulcerative ColitisVitamin D DeficiencyVitamin D Supplement
Interventions
DRUG

Caltrate

Patients in supplementary group were received with Caltrate 0.6 g/d and Mesalazine 4g/d orally at least 12 months, and those in non-supplementary only take Mesalazine 4g/d.

Trial Locations (1)

325000

SAHWenzhouMU, Wenzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER

NCT04276649 - A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis | Biotech Hunter | Biotech Hunter